Clinical Trials Sponsored by MedStar Hospitals

Total 100191 results

Medstar Health Research Institute
GlaxoSmithKline

Completed

Switching From Fondaparinux to Bivalirudin or Unfractionated Heparin in ACS Patients Undergoing PCI (SWITCHIII)

Acute Coronary Syndromes

United States, Canada
MedStar National Rehabilitation Network
HealthSouth

Completed

JOINTS Study - Joint Replacement Outcome in Inpatient Rehabilitation Facilities and Nursing Treatment Sites (JOINTS)

Osteoarthritis

United States
Medstar Health Research Institute
Pfizer

Completed

Sutent Adjunctive Treatment of Differentiated Thyroid Cancer (IIT Sutent)

Papillary Thyroid Cancer | Differentiated Thyroid Cancer | Follicular Thyroid Cancer

United States
Medstar Health Research Institute
GlaxoSmithKline

Unknown

Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)

Heparin-Induced Thrombocytopenia

United States
Matrix Biomed, Inc.
MedStar Georgetown

Not yet recruiting

MBM-02 (Tempol) for the Treatment of Glioblastoma Multiforme (GBM)

Glioblastoma | Glioblastoma Multiforme

United States
Medstar Health Research Institute
GlaxoSmithKline

Terminated

Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS

Metabolic Syndrome

United States
Marshall University
Arthrex, Inc.; Medstar Washington Hospital Center

Recruiting

Outcomes of the Nanoscopic Partial Meniscectomy Versus Standard Arthroscopic Partial Meniscectomy

Meniscus Tear

United States
Medstar Health Research Institute
Genentech, Inc.

Terminated

Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer

HER-2 Positive Metastatic Breast Cancer

United States
Medstar Health Research Institute
Genentech, Inc.

Completed

Cardiac Safety Study in Patients With HER2 + Breast Cancer (SAFE-HEaRt)

Left Ventricular Function Systolic Dysfunction | HER2 Positive Breast Cancer

United States
Cynthia West

Completed

Stop Atherosclerosis in Native Diabetics Study (SANDS)

Hypertension | Cardiovascular Disease | Diabetes | Carotid Atherosclerosis | Hyperlipidemia

United States
Medstar Health Research Institute
Georgetown University

Withdrawn

The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma

Hypothyroidism | Thyroid Carcinoma

United States
Medstar Health Research Institute
Cardinal Health

Completed

The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Venous Access-Site Closure

Cardiac Diagnostic Procedure | Cardiac Interventional Procedure | Femoral Access Site Closure

United States
Rebecca Torguson

Completed

Registry Experience at the Washington Hospital Center, DES - Xience V (REWARDS XV)

Coronary Artery Disease

United States
Biotronik AG
Medstar Health Research Institute

Unknown

BIOVALVE - I / II Clincial Investigation (BIOVALVE)

Aortic Valve Stenosis | Heart Valve Diseases

Belgium, Germany, Switzerland, Netherlands
Georgetown University
Medstar Health Research Institute

Withdrawn

Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

Gestational Diabetes

United States
Medstar Health Research Institute
Media Rez

Recruiting

mHealth for Breast Cancer Survivors With Insomnia

Insomnia | Breast Cancer Survivor

United States
Medstar Health Research Institute
Medtronic Cardiovascular

Active, not recruiting

CoreValve Evolut Pro Prospective Registry

Aortic Stenosis

United States
Rebecca Torguson

Completed

Registry Experience at the Washington Hospital Center, DES - Endeavor for Myocardial Infarction (REWARDS-EMI)

Coronary Artery Disease

United States
Darma Inc.
Medstar Health Research Institute

Completed

Pilot Clinical Evaluation of the RHEA Vital Sign Vigilance System in Hospital Patients Patients

Vital Sign Monitoring

United States
VeraLight, Inc.
Medstar Health Research Institute

Completed

Using SCOUT Noninvasive AGE Measurements to Forecast Diabetes Complications (MARC)

Type 1 Diabetes | Type 2 Diabetes

United States
Medstar Health Research Institute
Latham Fund

Recruiting

Treatment of Hypopigmented Scars With Bimatoprost

Burn Scar | Cicatrix | Scars | Cicatrix, Hypertrophic | Pigmentation Disorder | Scarring | Hypopigmented Skin | Hypopigmented Scar | Burns Laser

United States
SonoMedica, Inc.
Medstar Health Research Institute

Terminated

Evaluation of the CardioSond Electronic Stethoscope in the Detection of Coronary Artery Disease

Coronary Artery Disease

United States
Georgetown University
Medstar Health Research Institute

Completed

Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia

Aphasia

United States
Medstar Health Research Institute
Sequenom Laboratories

Completed

The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage

Miscarriage | Intrauterine Fetal Demise | Circulating Cell Free Fetal DNA

United States
Georgetown University
Medstar Health Research Institute

Completed

Safety of BB-12 Supplemented Strawberry Yogurt For Healthy Adults on Antibiotics (PHASE)

Adults on Antibiotics

United States
MedSIR

Not yet recruiting

Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression (ANALLISA)

Ovarian Cancer | Oligometastatic Disease | Serous Ovarian Tumor
MedSIR

Recruiting

A PoC Study to Evaluate Treatments' Efficacy by Monitoring MRD Using ctDNA in HR-positive/HER2-negative EBC Population (MiRaDoR)

Breast Cancer

Spain
MedSIR

Active, not recruiting

Chemotherapy-free Trastuzumab and Pertuzumab in HER2-positive Breast Cancer: FDG-PET Response-adapted Strategy. (PHERGain)

Breast Cancer

Spain, Italy, France, United Kingdom, Germany, Portugal, Belgium
MedSIR

Withdrawn

POL6326 (Balixafortide) Plus Nab-paclitaxel or Eribulin in Patients With HER2-negative Advanced Breast Cancer (POLTER)

Advanced Breast Cancer
MedSIR

Terminated

Checkpoint Blockade in COVID-19 Pandemic (COPERNICO)

COVID-19 | Pneumonia, Viral

Spain
MedSIR

Recruiting

Preoperative Window Opportunity Study With Giredestrant or Tamoxifen in Premenopausal Women With ER+/HER2[-] & Ki67≥10% (EMPRESS)

Breast Cancer | Breast Cancer, Early-Onset

Spain, France
MedSIR

Active, not recruiting

Evaluation of the Efficacy and Safety of Nal-IRI for Progressing Brain Metastases in Breast Cancer Patients (Phenomenal)

Breast Cancer Metastatic

Spain
MedSIR

Completed

Palbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast Cancer (PARSIFAL)

Metastatic Breast Cancer

Spain, Czechia, France, Germany, Italy, Russian Federation, United Kingdom
MedSIR

Completed

Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or Lapatinib (TRASTYVERE)

Breast Neoplasm

Spain
MedSIR

Terminated

Olaparib+Trastuzumab in HER2[+],Breast Cancer Susceptibility Gene (BRCA) Mutated Advanced Breast Cancer (OPHELIA)

Advanced Breast Cancer

Spain
MedSIR

Terminated

A Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single Agent (NOBROLA)

Breast Cancer

Spain
MedSIR

Completed

Molecular Mechanisms of Resistance and Sensitivity to Palbociclib Re-challenge in ER+ mBC (BioPER)

Metastatic Breast Cancer

Spain, Italy
MedSIR

Completed

Ph II Study of Pembrolizumab & Eribulin in Patients With HR+/HER2- MBC Previously Treated With Anthracyclines & Taxanes (KELLY)

Breast Cancer

Spain
MedSIR

Terminated

Trial With Eribulin or Eribulin+ Endocrine Therapy in Locally-recurrent or Metastatic Breast Cancer Patients

Breast Cancer

Spain
MedSIR

Completed

POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus (POEM)

Carcinoma, Endometrioid | mTOR Protein

Spain
MedSIR

Completed

Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment (MERIBEL)

Breast Neoplasm | Metastasis

Spain
SeaStar Medical

Terminated

Efficacy Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Kidney Injury

Acute Kidney Injury

United States
SeaStar Medical

Withdrawn

C2Rx Hemofiltration Treatment in Severe or Critically Ill Adults With COVID-19

COVID-19 | Continuous Renal Replacement Therapy | Pulmonary Edema
VA Office of Research and Development
Georgetown University; MedStar Hospitals

Completed

CAM in Veterans With Gulf War Illnesses (GW-CAM)

Gulf War Veterans' Illness

United States
Meditor SAS

Completed

Effects of Hemoperfusion With a Polymyxin B Membrane in Peritonitis With Septic Shock (ABDO-MIX)

Septic Shock | Peritonitis

France
SeaStar Medical

Completed

Safety and Efficacy of SCD in AKI or ARDS Patients Associated With COVID-19 Infections

AKI | COVID | ARDS

United States
Medstar Health Research Institute
Amenity Health, Inc.

Terminated

Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean Delivery

Obesity, Morbid | Wound Infection | Wound Complication

United States
Medstar Health Research Institute
Bristol-Myers Squibb

Completed

Solid Tumors Using Ixabepilone and Dasatinib

Solid Tumor

United States
Medstar Health Research Institute
Enzon Pharmaceuticals, Inc.

Withdrawn

Safety, Efficacy, and Pharmacokinetics of Amphotericin B Lipid Complex

Invasive Cryptococcosis

United States
George Mason University
MedStar National Rehabilitation Network

Completed

Mechanisms of Arm Recovery in Stroke Patients With Hand Paralysis

Stroke | Stroke, Ischemic | Hemiparesis | Cerebral Vascular Accident

United States

Clinical Trials Sponsored by MedStar Hospitals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations